Cyklokapron
FDA Approves Dotarem, a New MRI Agent »
"The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older.
Dotarem is a gadolinium-based"...
Cyklokapron
Cyklokapron®
(tranexamic acid) Injection
Antifibrinolytic agent
DRUG DESCRIPTION
Each mL of the sterile solution for intravenous injection contains 100 mg tranexamic acid and Water for Injection to 1 mL.
FORMULATION
Chemical Name: trans-4-(aminomethyl) cyclohexanecarboxylic acid. Structural Formula:
 |
Empirical Formula: C8H15NO2............................Molecular Weight: 157.2
Tranexamic acid is a white crystalline powder. The aqueous solution for injection has a pH of 6.5 to 8.0.
Last reviewed on RxList: 2/17/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Cyklokapron Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
